blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2761623

EP2761623 - PARTITIONED REACTION VESSELS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  23.12.2016
Database last updated on 29.10.2024
Most recent event   Tooltip23.12.2016Application deemed to be withdrawnpublished on 25.01.2017  [2017/04]
Applicant(s)For all designated states
GE Healthcare Limited
Amersham Place
Little Chalfont, Buckinghamshire HP7 9NA / GB
[N/P]
Former [2014/32]For all designated states
GE Healthcare Limited
Amersham Place Little Chalfont
Buckinghamshire HP7 9NA / GB
Inventor(s)01 / JACKSON, Alexander
Ge Healthcare Limited The Grove Centre
White Lion Road
Amersham Buckinghamshire HP7 9LL / GB
 [2014/32]
Representative(s)Serjeants LLP
Dock
75 Exploration Drive
Leicester, LE4 5NU / GB
[N/P]
Former [2014/32]Canning, Lewis R., et al
GE Healthcare Limited
Pollards Wood
Nightingales Lane
Chalfont St Giles
Buckinghamshire HP8 4SP / GB
Application number, filing date12834736.601.10.2012
WO2012US58212
Priority number, dateUS201161541177P30.09.2011         Original published format: US 201161541177 P
[2014/32]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2013049783
Date:04.04.2013
Language:EN
[2013/14]
Type: A1 Application with search report 
No.:EP2761623
Date:06.08.2014
Language:EN
The application published by WIPO in one of the EPO official languages on 04.04.2013 takes the place of the publication of the European patent application.
[2014/32]
Search report(s)International search report - published on:US04.04.2013
(Supplementary) European search report - dispatched on:EP22.12.2015
ClassificationIPC:G21G1/04, B01J19/00, C07B59/00, G21G1/00
[2016/03]
CPC:
B01J19/004 (EP,US); B01J19/2475 (US); B01J19/0093 (EP,US);
C07B59/00 (US); B01J2219/00799 (EP,US); B01J2219/00813 (EP,US);
B01J2219/00815 (EP,US); B01J2219/00817 (EP,US); B01J2219/00835 (EP,US);
B01J2219/00867 (EP,US); B01J2219/00873 (EP,US); B01J2219/00889 (EP,US);
B01J2219/00891 (EP,US); B01J2219/00907 (EP,US); G21G1/001 (EP,US) (-)
Former IPC [2014/32]G21G1/04
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/32]
TitleGerman:PARTITIONIERTE REAKTIONSGEFÄSSE[2014/32]
English:PARTITIONED REACTION VESSELS[2014/32]
French:RÉCIPIENTS DE RÉACTION CLOISONNÉS[2014/32]
Entry into regional phase18.03.2014National basic fee paid 
18.03.2014Search fee paid 
18.03.2014Designation fee(s) paid 
18.03.2014Examination fee paid 
Examination procedure18.03.2014Amendment by applicant (claims and/or description)
18.03.2014Examination requested  [2014/32]
22.07.2016Application deemed to be withdrawn, date of legal effect  [2017/04]
09.09.2016Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2017/04]
Fees paidRenewal fee
27.10.2014Renewal fee patent year 03
27.10.2015Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
31.10.201605   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XY]US3707353  (KUBIATOWICZ DAVID O) [X] 1,2,6-8,10 * abstract * * column 3, line 14 - column 4, line 47 * * column 5, line 1 - line 63 * * column 6, line 21 - line 69; figures 1, 3; examples 2, 3; claim - * [Y] 11-15;
 [X]WO9502049  (CAMBRIDGE MOLECULAR TECH [GB], et al) [X] 1,2,4,6,8 * abstract * * page 13, paragraph l - page 14, paragraph 1 * * page 14, paragraph l - page 17, paragraph 2; figures 3, 5, 6; claim - *;
 [X]US5833934  (ADLHART OTTO J [US]) [X] 1,2 * abstract * * column 2, line 40 - line 53 * * column 3, line 58 - column 4, line 5; figures 3-5 *;
 [Y]WO2006133732  (ADVANCED ACCELERATOR APPLIC [FR], et al) [Y] 11-15 * abstract * * page 14, line 26 - page 16, line 7; figure .; claim - *;
 [Y]US2011150714  (ELIZAROV ARKADIJ M [US], et al) [Y] 11-15 * abstract * * paragraph [0375] - paragraph [0390]; figures 25-27 *;
 [X]  - Annette Beck-Sickinger; Peter Weber, Kombinatorische Methoden in Chemie und Biologie, Spektrum Akademischer Verlag, (1999), pages 44 - 46, XP002751807 [X] 1,3-5,7-9 * figure 2.14 *
 [A]  - MATTHIAS GLASER ET AL, "Methods for 18F-labeling of RGD peptides: comparison of aminooxy not 18F|fluorobenzaldehyde condensation with 'click labeling' using 2- not 18F|fluoroethylazide, and S-alkylation with not 18F|fluoropropanethiol", AMINO ACIDS ; THE FORUM FOR AMINO ACID AND PROTEIN RESEARCH, SPRINGER-VERLAG, VI, (20081115), vol. 37, no. 4, ISSN 1438-2199, pages 717 - 724, XP019762383 [A] 1-15 * abstract * * page 720, column l, paragraph 4 - column r, paragraph 2 * * page 723, column r, paragraph l *
International search[Y]US3707353  (KUBIATOWICZ DAVID O);
 [Y]US3981981  (REUNANEN MATTI ANTERO);
 [Y]US6095356  (RITS MIRIAM [US]);
 [Y]US2007208164  (OLSZEWSKI JOHN D [US], et al);
 [Y]US2007217963  (ELIZAROV ARKADIJ M [US], et al);
 [Y]US2010243972  (VOCCIA SAMUEL [BE], et al);
 [A]  - ARMSTRONG ET AL., "Synthetic Strategy- Lecture 2", (2004), URL: http://www.ch.ic.ac.uk/local/organic/tutorial/2.01%20part%203%201ecture%202%20%28DC%29.PDF, (20111121), XP055145605
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.